APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 67 filers reported holding APTOSE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -75.0% | 3,079 | -41.7% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -38.5% | 5,279 | -45.5% | 0.00% | -50.0% |
| Q4 2021 | $13,000 | -89.1% | 9,679 | -82.2% | 0.00% | -90.5% |
| Q3 2021 | $119,000 | -77.8% | 54,529 | -66.2% | 0.02% | -78.6% |
| Q2 2021 | $535,000 | -47.8% | 161,279 | -6.0% | 0.10% | -58.3% |
| Q1 2021 | $1,025,000 | +38.3% | 171,539 | +1.4% | 0.24% | +26.3% |
| Q4 2020 | $741,000 | -14.4% | 169,214 | +17.2% | 0.19% | -34.0% |
| Q3 2020 | $866,000 | +6.3% | 144,364 | +11.7% | 0.28% | -9.6% |
| Q2 2020 | $815,000 | +4.4% | 129,214 | -1.8% | 0.31% | -12.6% |
| Q1 2020 | $781,000 | +42.0% | 131,554 | +35.6% | 0.36% | +73.3% |
| Q4 2019 | $550,000 | +186.5% | 97,029 | +5.4% | 0.21% | +139.5% |
| Q3 2019 | $192,000 | -13.1% | 92,029 | +8.2% | 0.09% | -9.5% |
| Q2 2019 | $221,000 | +39.9% | 85,029 | +7.9% | 0.10% | +17.3% |
| Q1 2019 | $158,000 | +43.6% | 78,829 | +37.3% | 0.08% | +12.5% |
| Q4 2018 | $110,000 | -17.9% | 57,429 | +11.4% | 0.07% | -10.0% |
| Q3 2018 | $134,000 | +19.6% | 51,539 | +80.8% | 0.08% | -33.3% |
| Q2 2018 | $112,000 | +220.0% | 28,500 | +147.8% | 0.12% | +361.5% |
| Q1 2018 | $35,000 | – | 11,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Annandale Capital, LLC | 74,666 | $209 | 0.05% |
| CALDWELL SUTTER CAPITAL, INC. | 92 | $258 | 0.00% |